EUVIMEDEUVIMED entdecken
MetaanalyseOpen Access · CC BY 4.0

Evaluating photodynamic therapy as an adjuvant treatment for neovascular AMD: A comprehensive meta-analysis

Swara M Sarvepalli, Ishani Kapoor, Kubra Sarici, Sunir J Garg, Majda Hadziahmetovic

Asia-Pacific Journal of Ophthalmology · 2025-03 · 14 (2) · 100173

DOI: 10.1016/j.apjo.2025.100173 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift Asia-Pacific Journal of Ophthalmology, 2025-03. Verfasst von Swara M Sarvepalli und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Indiana University, Indianapolis, IN, USA. Hauptthemen laut MEDLINE: Photochemotherapy, Visual Acuity, Wet Macular Degeneration. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: This study aimed to assess the role of photodynamic therapy (PDT) as an adjunct to anti-vascular endothelial growth factor (Anti-VEGF) intravitreal injections in the treatment of neovascular age-related macular degeneration (nvAMD). METHODS: PubMed, Cochrane Library, and ClinicalTrials.gov were searched for keywords "macular degeneration" and "photodynamic therapy" and "placebo" or "ranibizumab" or "bevacizumab" or "aflibercept" from inception to 2023. Included studies were peer-reviewed primary data reporting 12-month treatment results of nvAMD with anti-VEGF and PDT, anti-VEGF alone, intravitreal triamcinolone, or placebo. 23 studies were included in the final analysis. The major outcomes were best-corrected visual acuity (BCVA), central retinal thickness (CRT), and injection burden at 12 months. RESULTS: Anti-VEGF + PDT had better BCVA at 12 months compared to anti-VEGF (MD -0.07; 95 % CI -0.12, -0.01; P = 0.02). There was no significant difference in CRT at 12 months in anti-VEGF + PDT group versus anti-VEGF (MD -3.66; 95 % CI -10.28, 2.98; P = 0.28). Anti-VEGF + PDT group had significantly fewer injections compared to anti-VEGF (MD -1.76; 95 % CI -1.95, -1.58; P < 0.0001). There was no significant difference in pooled ocular adverse events between anti-VEGF + PDT versus anti-VEGF (MD 0.96; 95 % CI 0.68, 1.36; P = 0.41). CONCLUSIONS: PDT is a successful adjunctive to anti-VEGF injections for the treatment of nvAMD. The combination of the therapies leads to improved BCVA at 12 months, decreased injection burden, and no difference in ocular safety.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PhotochemotherapyVisual AcuityWet Macular DegenerationHumansAngiogenesis InhibitorsIntravitreal InjectionsVascular Endothelial Growth Factor ABevacizumabReceptors, Vascular Endothelial Growth FactorRanibizumabRecombinant Fusion Proteins

Stichwörter der Autor:innen

Anti-VEGFBest corrected visual acuityIntravitreal injectionNeovascular age-related macular degenerationPhotodynamic therapyVitreoretinal disease

Substanzen

Angiogenesis InhibitorsVascular Endothelial Growth Factor ABevacizumabReceptors, Vascular Endothelial Growth FactorRanibizumabafliberceptRecombinant Fusion Proteins

Autor:innen und Institutionen

  • Department of Ophthalmology, Indiana University, Indianapolis, IN, USA.
  • Drexel University College of Medicine, Philadelphia, PA, USA.
  • Department of Ophthalmology, Duke University, Durham, NC, USA.
  • Mid Atlantic Retina, The Retina Service of Wills Eye Hospital, Philadelphia, PA, USA.
  • Department of Ophthalmology, Duke University, Durham, NC, USA. Electronic address: majda.hadziahmetovic@duke.edu.

Zitieren

APA

Sarvepalli, S. M., Kapoor, I., Sarici, K., Garg, S. J., & Hadziahmetovic, M. (2025). Evaluating photodynamic therapy as an adjuvant treatment for neovascular AMD: A comprehensive meta-analysis. Asia-Pacific Journal of Ophthalmology, 14(2), 100173. https://doi.org/10.1016/j.apjo.2025.100173

Vancouver

Sarvepalli SM, Kapoor I, Sarici K, Garg SJ, Hadziahmetovic M. Evaluating photodynamic therapy as an adjuvant treatment for neovascular AMD: A comprehensive meta-analysis. Asia-Pacific Journal of Ophthalmology. 2025;14(2):100173. doi:10.1016/j.apjo.2025.100173

BibTeX
@article{Sarvepalli2025,
  author = {Sarvepalli, Swara M and Kapoor, Ishani and Sarici, Kubra and Garg, Sunir J and Hadziahmetovic, Majda},
  title = {Evaluating photodynamic therapy as an adjuvant treatment for neovascular AMD: A comprehensive meta-analysis},
  journal = {Asia-Pacific Journal of Ophthalmology},
  year = {2025},
  volume = {14},
  number = {2},
  pages = {100173},
  doi = {10.1016/j.apjo.2025.100173}
}
Kostenlos starten →